Senti Biosciences is trading 7.02% down at $0.42 in after-hours trading, with no confirmed company-specific announcement explaining the decline.
- It closed August 14, 2026 at $0.45 after a 16.93% regular-session gain.
- Latest identifiable developments are the July 15 strategic transaction and an August 18 annual meeting involving merger, share-issuance, and reverse-split proposals; neither directly explains this move.